Assignee
NIVALIS THERAPEUTICS INC
US·10 granted patents·3 pending applications·14 citations·filing 2015–2016
Top patents by PatentIndex Score
13 records- 0186US9221810B2Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Dec 29, 2015·4 cites·15 claims
- 0284US9364481B2Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Jun 14, 2016·3 cites·22 claims
- 0383US9315462B2Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Apr 19, 2016·3 cites·14 claims
- 0480US9433618B2Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2016·Granted Sep 6, 2016·2 cites·9 claims
- 0575US9498466B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Nov 22, 2016·1 cites·11 claims
- 0674US9856219B2Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2016·Granted Jan 2, 2018·1 cites·14 claims
- 0763US9814700B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsNIVALIS THERAPEUTICS INC·Filed 2016·Granted Nov 14, 2017·0 cites·21 claims
- 0859US2016279117A1Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase InhibitorsNIVALIS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 0958US2016108011A1Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase InhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1056US9717706B2Chromone inhibitors of S-nitrosoglutathione reductaseNIVALIS THERAPEUTICS INC·Filed 2015·Granted Aug 1, 2017·0 cites·12 claims
- 1151US9283229B2Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Mar 15, 2016·0 cites·17 claims
- 1250US9707212B2S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Jul 18, 2017·0 cites·14 claims
- 1341US2017281612A1Methods for the Treatment of Cystic FibrosisNIVALIS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NIVALIS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →